Did you stop by the KBI Booth at BIO International 2023 for coffee and donuts and a chat with our team? In case you missed it, it's not too late! You can catch up on the highlights from this year's event - from a photo gallery to video interviews with our leadership team - to learn more about the latest news from KBI and what's coming next.
We caught up with Tim Lowery, President at JSR Life Sciences, as well as J.D. Mowery, CEO at KBI Biopharma, Tony Fraij, COO at KBI Biopharma, and Sigma Mostafa, CSO at KBI Biopharma, on the floor of BIO International 2023. Hear directly from the executive team as they discuss the operational consolidation of KBI and Selexis and how this streamlined structure enhances operational efficiencies and accelerates innovation for global biopharma customers.
We caught up with Aaron Pilling, Ph.D., Senior Director of Process Development, on the floor of BIO International 2023. Hear from Aaron as he discusses the KBI PUREplatform™, a premium microbial cell line development (CLD) platform that features unmatched efficiencies in a microbial expression system for biopharmaceutical production.
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future. The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future state of biotech. Including areas like therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital.